This opportunity is no longer accepting applications.
grant PAR-23-193

Chemical Synthesis and Optimization Facility for Advancing Non-Hormonal Contraceptive and Reproductive Health Product Development

This grant opportunity from NICHD provides support for preclinical studies to help develop new contraceptive and reproductive health therapies. The aim is to advance promising candidates to the stage where they can be tested under regulatory approvals like Investigational Device Exemption (IDE) or Investigational New Drug (IND).

The NICHD's facility offers preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies. The goal is to enable a preclinical candidate for IND/IDE study(ies) that offers a safe therapeutic option in contraception and reproductive healt…

Funding Source

Agency: National Institutes of Health
Sub-agency: <em>Eunice Kennedy Shriver</em> National Institute of Child Health and Human Development

Eligibility

Private Institutions of Higher Education
Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
For-Profit Organizations (Other than Small Businesses)
Eligible Agencies of the Federal Government
Native American Tribal Organizations (other than Federally recognized tribal governments)

  • Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
  • Required registrations (must be completed before submission; can take 6+ weeks): SAM (active; renew at least annually; CAGE code for domestic organizations), NCAGE code for foreign organizations (to re…

Dates

Opportunity Released: May 19, 2023
Open for Submission: May 19, 2023
Submission Deadline: April 3, 2026
Application Window Closes: April 3, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.